Drugs as a determinant of public health
Abstract
All drugs registered on the market must be safe, of proven efficacy and quality – and only such drugs are used by doctors in clinical studies or private practice. Among many health determinants health care system is of some importance and drugs as an element of this system are interrelated with other determinants, i.e. with micro- and macroeconomics. Since industrialisation of health, medicalisation of life and the politicisation of medicine are mutually reinforcing at present times we should recognize drugs as determinants of “lost” health immanently intertwined with other determinants influenced by new technologies like cybermedicine or telemedicine.
Downloads
References
Brownson R.C., BakerE.A., Left T.L., Gillespie K.N., Evidence Based Public Health, Oxford University Press 2004.
McGlynn E.A., Asch S.M., Adams J., Keesey J., Hicks J., DeCristofaro A., Kerr E.A., The quality of health care delivered to adults in the United States; New Engl. J. Med. 2003, 348; 2635.
Health Canada – National Forum on Health – Determinants of Health Working Group Synthesis Report, 2005
Greenberg D., Rosen A.B., Olchanski N.V., Stone P.W., Nadai J., Neumann P.J., Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis; BMJ, doi: 10.1136/bmj.38079. 502326. AE (2005).
Marinker M., Health Targets in Europe: Polity, progress and promise, BMJ Books 2002.
Detels R., McEwen J., Beaglehole R., Tanaka H., Oxford Textbook of Public Health, Oxford University Press 2002.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2006 Medical Journal of the Rzeszow University
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
